Cellebrite DI Statistics
Total Valuation
Cellebrite DI has a market cap or net worth of $2.15 billion. The enterprise value is $1.86 billion.
| Market Cap | 2.15B |
| Enterprise Value | 1.86B |
Important Dates
The next confirmed earnings date is Thursday, May 23, 2024, before market open.
| Earnings Date | May 23, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Cellebrite DI has 205.30 million shares outstanding. The number of shares has decreased by -2.68% in one year.
| Shares Outstanding | 205.30M |
| Shares Change (YoY) | -2.68% |
| Shares Change (QoQ) | -4.83% |
| Owned by Insiders (%) | 49.34% |
| Owned by Institutions (%) | 42.48% |
| Float | 55.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 32.48 |
| PS Ratio | 6.61 |
| Forward PS | 5.59 |
| PB Ratio | 62.83 |
| P/FCF Ratio | 22.83 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 43.02, with an EV/FCF ratio of 19.76.
| EV / Earnings | n/a |
| EV / Sales | 5.72 |
| EV / EBITDA | 43.02 |
| EV / EBIT | 55.98 |
| EV / FCF | 19.76 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.41.
| Current Ratio | 1.66 |
| Quick Ratio | 1.50 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 0.33 |
| Debt / FCF | 0.15 |
| Interest Coverage | 0.31 |
Financial Efficiency
Return on equity (ROE) is -251.30%.
| Return on Equity (ROE) | -251.30% |
| Return on Assets (ROA) | -17.60% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $322,530 |
| Profits Per Employee | -$80,456 |
| Employee Count | 1,008 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 5.29 |
Taxes
In the past 12 months, Cellebrite DI has paid $5.54 million in taxes.
| Income Tax | 5.54M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +87.63% in the last 52 weeks. The beta is 1.53, so Cellebrite DI's price volatility has been higher than the market average.
| Beta (1Y) | 1.53 |
| 52-Week Price Change | +87.63% |
| 50-Day Moving Average | 11.16 |
| 200-Day Moving Average | 8.67 |
| Relative Strength Index (RSI) | 39.85 |
| Average Volume (30 Days) | 1,014,791 |
Short Selling Information
The latest short interest is 2.48 million, so 1.21% of the outstanding shares have been sold short.
| Short Interest | 2.48M |
| Short Previous Month | 2.62M |
| Short % of Shares Out | 1.21% |
| Short % of Float | 4.44% |
| Short Ratio (days to cover) | 2.34 |
Income Statement
In the last 12 months, Cellebrite DI had revenue of $325.11 million and -$81.10 million in losses. Loss per share was -$0.43.
| Revenue | 325.11M |
| Gross Profit | 271.88M |
| Operating Income | 33.24M |
| Pretax Income | -75.56M |
| Net Income | -81.10M |
| EBITDA | 43.25M |
| EBIT | 33.24M |
| Loss Per Share | -$0.43 |
Balance Sheet
The company has $302.92 million in cash and $14.13 million in debt, giving a net cash position of $288.79 million or $1.41 per share.
| Cash & Cash Equivalents | 302.92M |
| Total Debt | 14.13M |
| Net Cash | 288.79M |
| Net Cash Per Share | $1.41 |
| Equity / Book Value | 34.21M |
| Book Value Per Share | 0.17 |
| Working Capital | 168.26M |
Cash Flow
In the last 12 months, operating cash flow was $102.06 million and capital expenditures -$7.92 million, giving a free cash flow of $94.14 million.
| Operating Cash Flow | 102.06M |
| Capital Expenditures | -7.92M |
| Free Cash Flow | 94.14M |
| FCF Per Share | $0.50 |
Margins
Gross margin is 83.63%, with operating and profit margins of 10.22% and -24.95%.
| Gross Margin | 83.63% |
| Operating Margin | 10.22% |
| Pretax Margin | -23.24% |
| Profit Margin | -24.95% |
| EBITDA Margin | 13.30% |
| EBIT Margin | 10.22% |
| FCF Margin | 28.96% |
Dividends & Yields
Cellebrite DI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.68% |
| Shareholder Yield | 2.68% |
| Earnings Yield | -3.77% |
| FCF Yield | 4.38% |
Analyst Forecast
The average price target for Cellebrite DI is $12.92, which is 23.40% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.92 |
| Price Target Difference | 23.40% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 17.47% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cellebrite DI has an Altman Z-Score of 4.09 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.09 |
| Piotroski F-Score | 5 |